Drug Discovery App CS WP

  1. Bispecific Antibodies Unleashed 5/16/2024

    Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.

  2. Rapid Discovery And Characterization Of Monoclonal Antibodies Against The SARS-CoV-2 Delta Spike Protein 5/16/2024

    Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.

  3. Leveraging The Immunological Diversity Of The Pentamice® Platform For Covid-19 Antibody Discovery 5/16/2024

    Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.

  4. The Value Of Engaging A Single CDMO For Comprehensive Biologics Services 5/16/2024

    By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.

  5. The Shift Toward Western Pharmaceutical Manufacturing 5/16/2024

    Delve into the complexities of securing and de-risking pharmaceutical supply chains in light of vulnerabilities and prompting renewed conversations about reshoring production.

  6. Resource Savings Through Effective Global Trade Compliance 5/16/2024

    Ensure consistent planning, accurate cost estimation, and enhanced delivery timelines for materials shipped across borders by partnering with a CDMO equipped with a dedicated trade compliance team.

  7. Why Should CDMOs Adhere To The New CDER's Rating System? 5/16/2024

    Delve into the benefits of the FDA's Quality Management Maturity (QMM) program, the rating system’s evaluation criteria, challenges, and steps to overcome these hurdles and achieve excellence.

  8. Developing A Large-Scale Tangential Flow Filtration Process 5/13/2024

    Discover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.

  9. Review Of Applications And Processes In Fixed-Bed Bioreactors 5/6/2024

    Gain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.

  10. Lentiviral Vector Production Using Single-Use Bioreactors 5/6/2024

    Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.